Cambex Corporation
Cambex Corporation Fundamental Analysis
Cambex Corporation (CBEX) shows moderate financial fundamentals with a PE ratio of 0.00, profit margin of 38.70%, and ROE of -28.29%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 12.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CBEX's fundamental strength across five key dimensions:
Efficiency Score
WeakCBEX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCBEX trades at attractive valuation levels.
Growth Score
ModerateCBEX shows steady but slowing expansion.
Financial Health Score
ModerateCBEX shows balanced financial health with some risks.
Profitability Score
ModerateCBEX maintains healthy but balanced margins.
Key Financial Metrics
Is CBEX Expensive or Cheap?
P/E Ratio
CBEX trades at 0.00 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CBEX's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Cambex Corporation at -0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.44 times EBITDA. This is generally considered low.
How Well Does CBEX Make Money?
Net Profit Margin
For every $100 in sales, Cambex Corporation keeps $38.70 as profit after all expenses.
Operating Margin
Core operations generate 13.06 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-28.29 in profit for every $100 of shareholder equity.
ROA
Cambex Corporation generates $2.67 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Cambex Corporation generates strong operating cash flow of $685.10K, reflecting robust business health.
Free Cash Flow
Cambex Corporation generates strong free cash flow of $685.10K, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.03 in free cash annually.
FCF Yield
CBEX converts 287.06% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.003
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.001
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.24
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.11
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.28
vs 25 benchmark
ROA
Return on assets percentage
2.67
vs 25 benchmark
ROCE
Return on capital employed
-0.11
vs 25 benchmark
How CBEX Stacks Against Its Sector Peers
| Metric | CBEX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.00 | 37.37 | Better (Cheaper) |
| ROE | -28.29% | 998.00% | Weak |
| Net Margin | 38.70% | 5890844717.00% | Weak |
| Debt/Equity | -0.24 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 0.11 | 5.05 | Weak Liquidity |
| ROA | 266.86% | -295102.00% (disorted) | Strong |
CBEX outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Cambex Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta